Clinical Trials Directory

Trials / Completed

CompletedNCT05987969

Efficacy and Safety of the Alena App as a Treatment for Social Anxiety Disorder

Efficacy, Tolerability and Safety of a Smartphone-delivered, Fully Automatic Cognitive Behavioural Therapy Programme for Social Anxiety

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
250 (actual)
Sponsor
Aya Technologies Limited · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The present study is a randomised controlled trial that seeks to investigate the efficacy and safety of the Alena app as a treatment for social anxiety disorder.

Detailed description

This will be a 10-week web-based parallel-group unblinded randomised controlled trial with an 8-week intervention period and a 2-week follow-up post-intervention. Participants will be randomly allocated to receive access to the Alena app or to a wait list control group, in a 1:1 ratio. The Alena app primarily comprises CBT-based therapy for social anxiety based on the Clark and Wells model, as well as cognitive assessments, calming exercises and a community forum.

Conditions

Interventions

TypeNameDescription
OTHER"Alena" mobile applicationThis mobile application primarily comprises CBT-based therapy for social anxiety based on the Clark and Wells model, as well as cognitive assessments, calming exercises and a community forum.

Timeline

Start date
2023-03-20
Primary completion
2023-06-07
Completion
2023-06-07
First posted
2023-08-14
Last updated
2023-08-14

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05987969. Inclusion in this directory is not an endorsement.